Naf1α is phosphorylated in mitotic phase and required to protect cells against apoptosis

Biochemical and Biophysical Research Communications

Volumn 367, Issue 2, 2008, Pages 364-369

  Zhang, Shengliang ^a   Mahalingam, Marthandan ^a   Tsuchida, Nobuo ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

apoptosis; Cell cycle; Mitotic phase; Naf1 ; Protein phosphorylation

Indexed keywords

EPIDERMAL GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN NEF ASSOCIATED FACTOR 1 ALPHA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRICHOSTATIN A; UNCLASSIFIED DRUG; CARRIER PROTEIN; NAF1ALPHA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL CYCLE M PHASE; CELL PROTECTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MITOSIS; OSTEOBLAST; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; CELL CYCLE; CELL LINE; CYTOLOGY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY;

APOPTOSIS; CARRIER PROTEINS; CELL CYCLE; CELL LINE; HUMANS; MITOSIS; OSTEOBLASTS; PHOSPHORYLATION;

EID: 38349057332     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.141     Document Type: Article

References (28)

1. Fukushi M., Dixon J., Kimura T., Tsurutani N., Dixon M.J., and Yamamoto N. Identification and cloning of a novel cellular protein Naf1, Nef-associated factor 1, that increases cell surface CD4 expression. FEBS Lett. 442 (1999) 83-88
2. Gupta K., Ott D., Hope T.J., Siliciano R.F., and Boeke J.D. A human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions. J. Virol. 74 (2000) 11811-11824
3. Zhang S., Fukushi M., Hashimoto S., Gao C., Huang L., Fukuyo Y., Nakajima T., Amagasa T., Enomoto S., Koike K., Miura O., Yamamoto N., and Tsuchida N. A new ERK2 binding protein, Naf1, attenuates the EGF/ERK2 nuclear signaling. Biochem. Biophys. Res. Commun. 297 (2002) 17-23
4. Wright J.H., Munar E., Jameson D.R., Andreassen P.R., Margolis R.L., Seger R., and Krebs E.G. Mitogen-activated protein kinase kinase activity is required for the G(2)/M transition of the cell cycle in mammalian fibroblasts. Proc. Natl. Acad. Sci. USA 96 (1999) 11335-11340
5. Liu X., Yan S., Zhou T., Terada Y., and Erikson R.L. The MAP kinase pathway is required for entry into mitosis and cell survival. Oncogene 23 (2004) 763-776
6. McCubrev J.A.., Steelman L.S., Chappel W.H., Abrahams S.L., et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Biochem. Biophys. Acta 1773 (2007) 1263-1284
7. Wullaert A., Wielockx B., Huffel S.V., Bogaert V., Geest B.D., Papeleu P., Schotte P., Bakkouri K.E., Heyninck K., Libert C., and Beyaert R. Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality. Hepatology 42 (2005) 381-389
8. Mussacchio A., and Salmon E.D. The spindle-assembly checkpoint in space and time. Nat. Rev. Mol. Cell Biol. 8 (2007) 379-393
9. Loebrich M., and Jeggo P.A. The impact of a negligent G2/M checkpoint on genomic instability and cancer induction. Nat. Rev. Cancer 7 (2007) 861-869
10. Avion Y., and Oren M. Living with p53, dying of p53. Cell 130 (2007) 597-600
11. Yoshida M., Kijima M., Akita M., and Beppu T. Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. J. Biol. Chem. 265 (1990) 17174-17179
12. Blagosklonny M.V., Robey R., Sackett D.L., Du L., Traganos F., Darzynkiewicz Z., Fojo T., and Bates S.E. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. Mol. Cancer Ther. 1 (2002) 937-941
13. Noh E.J., and Lee J.S. Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. Biochem. Biophys. Res. Commun. 310 (2003) 267-273
14. Henderson C., Mizzau M., Paroni G., Maestro R., Schneider C., and Brancolini C. Role of caspases, Bid, and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A (TSA) and suberoylanilide hydroxamic acid (SAHA). J. Biol. Chem. 278 (2003) 12579-12589
15. Tanaka M., Ueda A., Kanamori H., Ideguchi H., Yang J., Kitajima S., and Ishigatsubo Y. Cell-cycle-dependent regulation of human aurora A transcription is mediated by periodic repression of E4TF1. J. Biol. Chem. 277 (2002) 10719-10726
16. Dryden S.C., Nahhas F.A., Nowak J.E., Goustin A.S., and Tainsky M.A. Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle. Mol. Cell Biol. 23 (2003) 3173-3185
17. Lew J. MAP kinases and CDKs: kinetic basis for catalytic activation. Biochemistry 42 (2003) 849-856
18. Nigg E.A. Mitotic kinases as regulators of cell division and its checkpoints. Nat. Rev. Mol. Cell Biol. 2 (2001) 21-32
19. Tobey R.A., and Crissman H.A. Preparation of large quantities of synchronized mammalian cells in late G1 in the pre-DNA replicative phase of the cell cycle. Exp. Cell Res. 75 (1972) 460-464
20. Hoque M.T., and Ishikawa F. Human chromatid cohesin component hRad21 is phosphorylated in M phase and associated with metaphase centromeres. J. Biol. Chem. 276 (2001) 5059-5067
21. Hans F., and Dimitrov S. Histone H3 phosphorylation and cell division. Oncogene 20 (2001) 3021-3027
22. Kleinberger-Doron N., Shelah N., Capone R., Gazit A., and Levitzli A. Inhibition of cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase. Exp. Cell Res. 241 (1998) 340-351
23. Crane R., Gadea B., Littlepage L., Wu H., and Ruderman J.V. Aurora A, meiosis and mitosis. Biol. Cell 96 (2004) 215-229
24. Murray A.W. Recycling the cell cycle: cyclins revisited. Cell 116 (2004) 221-234
25. Blagosklonny M.V., Robey R., Sackett D.L., Du L., Traganos F., Darzynkiewicz Z., Fojo T., and Bates S.E. Histone deacetylase inhibitors all induce p21 but differentially cause tubulin acetylation, mitotic arrest, and cytotoxicity. Mol. Cancer Ther. 11 (2002) 937-941
26. Peters J.M. The anaphase-promoting complex: proteolysis in mitosis and beyond. Mol. Cell 9 (2002) 931-943
27. Gallagher J., Howlin J., McCarthy C., Murphy E.P., Bresnihan B., FitzGerald O., Godson C., Brady H.R., and Martin F. Identification of Naf1/ABIN-1 among TNF-α-induced expressed genes in human synoviocytes using oligonucleotide microarrays. FEBS Lett. 551 (2003) 8-12
28. Cimini D., Mattiuzzo M., Torosantucci L., and Degrassi F. Histone hyperacetylation in mitosis prevents sister chromatid separation and produces chromosome segregation defects. Mol. Biol. Cell 14 (2003) 3821-3833